Company: NDRA
Filing Date: 2025-07-09
Form Type: 8-K
Source: 0001654954-25-007893
Chunk: 0

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-07-09
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02

Results of Operations and Financial Condition.

On July 9, 2025, ENDRA Life Sciences Inc. (the “ Company”) filed a Registration Statement (the “ Prospectus”) on Form S-1 (No. 333-288575) pursuant to the Securities Act of 1933, as amended (the “ Securities Act”), relating to a public offering (the “ Offering”) of shares of the Company’s common stock and warrants to purchase shares of the Company’s common stock. The Prospectus contains select preliminary unaudited estimated financial results for the fiscal quarter ended June 30, 2025. Such preliminary estimated results are furnished in the excerpt from the Prospectus attached hereto as Exhibit 99.1.

The information under Item 2.02 and in Exhibit 99.1 to this Current Report on Form 8-K are being furnished and shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.